News
Eli Lilly to Open a Diabetes-Focused Research Center in China
Eli Lilly and Company announced plans to open a research center focused on diabetes in China, where the incidence of the disease has reached epidemic...
News
Pfizer’s Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
Pfizer Inc announced today that the Japanese Ministry of Health, Labour and Welfare approved Lyrica® (pregabalin) capsules for the treatment of peripheral neuropathic...
News
GlaxoSmithKline receives approval in Japan from the Ministry of Health
GlaxoSmithKline announced that it has received approval in Japan from the Ministry of Health, Labour and Welfare for Revolade (eltrombopag) for the treatment of the...
News
Dako and Quintiles form alliance to speed development of personalized medicine
Dako, a Danish-based world leader in tissue-based cancer diagnostics, and Quintiles, the world’s leading bio pharmaceutical services companies, announced a strategic alliance to advance personalized...
News
PRADAX gains approval in Canada for stroke prevention in atrial fibrillation
Health Canada, the Canadian health authority, has approved PRADAX™ (dabigatran etexilate), 1 Boehringer Ingelheim’s novel, oral direct thrombin inhibitor 2 for the prevention of stroke...
News
Significant Milestone for Tengion Clinical Program Currently Enrolling Bladder Cancer Patients
Tengion, Inc., a leader in regenerative medicine, announced that surgeons at the University of Chicago have implanted its Neo-Urinary Conduit(TM) in the first patient as...
News
AstraZeneca initiates phase IIB study for AZD9773 (CytoFab) as a treatment for severe sepsis
AstraZeneca announced that it has commenced dosing patients in a global Phase IIb study to compare the efficacy and safety of AZD9773 (CytoFab) with placebo...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.